Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Mar-24 4:15 PM View:  | Berkowitz Noah Chief Medical Officer | Arvinas, Inc. (ARVN) | 18-Mar-24 | Grant | 63,452 | -- | -- | 100% 0 to 63.45K | |
| 27-Feb-24 6:33 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Sale | 1,701 | $47.05 | $80,032.00 | (1%) 149.22K to 147.52K | |
| 27-Feb-24 6:34 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Sale | 1,699 | $47.05 | $79,937.90 | (2%) 69.22K to 67.52K | |
| 27-Feb-24 6:35 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 23-Feb-24 | Grant | 124,450 | -- | -- | 14% 917.43K to 1.04M | |
| 27-Feb-24 6:33 PM View: | Loomis David K Chief Accounting Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Grant | 5,750 | -- | -- | 209% 2.75K to 8.5K | |
| 27-Feb-24 6:35 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 23-Feb-24 | Sale | 5,196 | $47.05 | $244,472.00 | (< 1%) 1.04M to 1.04M | |
| 27-Feb-24 6:34 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Sale | 1,702 | $47.05 | $80,079.10 | (< 1%) 183.62K to 181.92K | |
| 27-Feb-24 6:33 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Grant | 39,250 | -- | -- | 36% 109.97K to 149.22K | |
| 27-Feb-24 6:34 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 23-Feb-24 | Grant | 39,250 | -- | -- | 131% 29.96K to 69.22K | |
| 08-Jan-24 4:39 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 04-Jan-24 | Option Exercise | 8,252 | $16.00 | $132,032.00 | 8% 101.72K to 109.97K | |
| 14-Aug-23 5:27 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 11-Aug-23 | Option Exercise | 4,010 | -- | -- | 15% 27.28K to 31.29K | |
| 14-Aug-23 5:27 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 11-Aug-23 | Option Sale | 1,324 | $24.39 | $32,288.50 | (4%) 31.29K to 29.96K | |
| 03-Mar-23 10:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Sale | 1,745 | $29.53 | $51,529.90 | (< 1%) 185.36K to 183.62K | |
| 03-Mar-23 10:00 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Exercise | 17,510 | -- | -- | 2% 905.79K to 923.3K | |
| 03-Mar-23 10:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Exercise | 2,685 | -- | -- | 3% 100.09K to 102.77K | |
| 03-Mar-23 10:00 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Sale | 5,878 | $29.53 | $173,577.00 | (< 1%) 923.3K to 917.43K | |
| 03-Mar-23 10:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Exercise | 4,791 | -- | -- | 3% 180.57K to 185.36K | |
| 03-Mar-23 10:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 01-Mar-23 | Option Sale | 1,051 | $29.53 | $31,036.00 | (1%) 102.77K to 101.72K | |
| 24-Feb-23 4:58 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 22-Feb-23 | Grant | 19,125 | -- | -- | 235% 8.15K to 27.28K | |
| 24-Feb-23 4:57 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 22-Feb-23 | Grant | 61,975 | -- | -- | 7% 843.82K to 905.79K | |
| 24-Feb-23 4:56 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 22-Feb-23 | Grant | 19,125 | -- | -- | 24% 80.96K to 100.09K | |
| 24-Feb-23 4:59 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 22-Feb-23 | Grant | 19,125 | -- | -- | 12% 161.45K to 180.57K | |
| 16-Aug-22 4:42 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 12-Aug-22 | Option Exercise | 4,010 | -- | -- | 74% 5.4K to 9.41K | |
| 16-Aug-22 4:42 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 12-Aug-22 | Option Sale | 1,258 | $68.99 | $86,794.50 | (13%) 9.41K to 8.15K | |
| 18-Apr-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Apr-22 | Planned Option Sale | 16,188 | $66.44 | $1,075,560.00 | (40%) 40.94K to 24.75K | |
| 18-Apr-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Apr-22 | Sale (Planned) | 4,772 | $66.44 | $317,059.00 | (19%) 24.75K to 19.98K | |
| 18-Apr-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Apr-22 | Option Exercise | 16,188 | $16.00 | $259,008.00 | 65% 24.75K to 40.94K | |
| 01-Apr-22 8:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 31-Mar-22 | Gift | 3,000 | -- | -- | (4%) 83.96K to 80.96K | |
| 15-Mar-22 8:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 11-Mar-22 | Option Exercise | 15,000 | $16.00 | $240,000.00 | 9% 161.45K to 176.45K | |
| 15-Mar-22 8:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 11-Mar-22 | Planned Option Sale | 15,000 | $70.00 | $1,050,000.00 | (9%) 176.45K to 161.45K | |
| 04-Mar-22 9:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Exercise | 2,686 | -- | -- | 3% 82.14K to 84.83K | |
| 04-Mar-22 9:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Exercise | 4,791 | -- | -- | 3% 158.25K to 163.04K | |
| 04-Mar-22 9:00 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Exercise | 17,511 | -- | -- | 2% 832.33K to 849.84K | |
| 04-Mar-22 9:00 PM View: | Houston John G President and CEO Director | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Sale | 6,024 | $63.94 | $385,175.00 | (< 1%) 849.84K to 843.82K | |
| 04-Mar-22 9:00 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Sale | 1,593 | $63.94 | $101,856.00 | (< 1%) 163.04K to 161.45K | |
| 04-Mar-22 9:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 04-Mar-22 | Option Sale | 869 | $63.94 | $55,563.90 | (1%) 84.83K to 83.96K | |
| 03-Mar-22 9:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 01-Mar-22 | Option Exercise | 3,500 | $16.00 | $56,000.00 | 4% 78.64K to 82.14K | |
| 17-Feb-22 9:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 15-Feb-22 | Option Exercise | 20,000 | $19.36 | $387,200.00 | 25% 78.64K to 98.64K | |
| 17-Feb-22 9:00 PM View: | Taylor Ian Chief Scientific Officer | Arvinas, Inc. (ARVN) | 15-Feb-22 | Planned Option Sale | 20,000 | $73.02 | $1,460,320.00 | (20%) 98.64K to 78.64K | |
| 19-Jan-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Jan-22 | Sale (Planned) | 4,772 | $65.55 | $312,826.00 | (16%) 29.52K to 24.75K | |
| 19-Jan-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Jan-22 | Option Exercise | 16,188 | $16.00 | $259,008.00 | 55% 29.52K to 45.71K | |
| 19-Jan-22 9:00 PM View: | Morrison Briggs Director | Arvinas, Inc. (ARVN) | 14-Jan-22 | Planned Option Sale | 16,188 | $65.55 | $1,061,190.00 | (35%) 45.71K to 29.52K | |
| 04-Jan-22 9:00 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 30-Dec-21 | Option Exercise | 20,000 | $41.53 | $830,600.00 | 370% 5.4K to 25.4K | |
| 04-Jan-22 9:00 PM View: | Peck Ronald Chief Medical Officer | Arvinas, Inc. (ARVN) | 30-Dec-21 | Market Option Sale (Planned) | 20,000 | $80.61 | $1,612,260.00 | (79%) 25.4K to 5.4K | |
| 21-Dec-21 9:15 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 17-Dec-21 | Option Exercise | 15,000 | $16.00 | $240,000.00 | 9% 158.25K to 173.25K | |
| 21-Dec-21 9:15 PM View: | Cassidy Sean A Chief Financial Officer | Arvinas, Inc. (ARVN) | 17-Dec-21 | Market Option Sale (Planned) | 15,000 | $70.00 | $1,050,000.00 | (9%) 173.25K to 158.25K | |
| 16-Dec-21 9:30 PM View: | Ratcliffe Liam Director | Arvinas, Inc. (ARVN) | 16-Dec-21 | Market Sale | 85,705 | $69.36 | $5,944,420.00 | (32%) 271.39K to 185.69K | < 1% |
| 16-Dec-21 9:30 PM View: | Ratcliffe Liam Director | Arvinas, Inc. (ARVN) | 15-Dec-21 | Market Sale | 113,536 | $66.81 | $7,584,960.00 | (29%) 384.93K to 271.39K | (4%) |
| 16-Dec-21 9:30 PM View: | Ratcliffe Liam Director | Arvinas, Inc. (ARVN) | 14-Dec-21 | Market Sale | 156,464 | $65.86 | $10,304,000.00 | (29%) 541.39K to 384.93K | (5%) |
| 15-Nov-21 9:45 PM View: | Ratcliffe Liam Director | Arvinas, Inc. (ARVN) | 15-Nov-21 | Market Sale | 21,284 | $84.87 | $1,806,470.00 | (4%) 562.67K to 541.39K | < 1% |
